Highlights Sailong Pharmaceutical Group Co.,Ltd.

Equities

002898

CNE1000032S5

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 11/06/2024 am IST			5-day change	1st Jan Change
8.84 ^CNY	-0.23%		-5.86%	-36.72%

19/04	Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
08/04	Sailong Pharmaceutical Group Co.,Ltd. Approves Board Elections	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	19/04	CI
Sailong Pharma's Unit Gets Nod to Market Pregabalin	08/03	MT
Sailong Pharma Gets Registration Certificate for Pregabalin Capsules	04/03	MT
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	19/23/19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	19/23/19	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	28/22/28	CI
Sailong Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/22/26	CI
Sailong Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	26/21/26	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	25/21/25	CI
Wu Gulin signed share transfer agreement to acquire Hunan Shenglong Real Estate Co., Ltd. from Zhuhai Sailong Pharmaceutical Co.,Ltd. for CNY 10.2 million.	18/21/18	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Proposes No Final Dividend for 2020	01/21/01	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Earnings Results for the First Quarter Ended March 31, 2021	29/21/29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	29/21/29	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	27/20/27	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	10/20/10	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Announces Implementation of A Share Dividend for the Year 2019, Payable on 16 July 2020	09/20/09	CI
Zhuhai Sailong Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2019	22/20/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Sailong Pharmaceutical Group Co.,Ltd.

Equities

002898

CNE1000032S5

Highlights

Filters